Filter
10889
Filtered Results: 10889
Text search:
patients
Featured
Recommendations
1064
New Publications
2539
Language
Document type
No document type
5816
Guidelines
1617
Studies & Reports
1550
Manuals
533
Fact sheets
399
Strategic & Response Plan
318
Training Material
210
Situation Updates
138
Resource Platforms
86
Infographics
76
Brochures
57
Online Courses
52
Videos
32
App
4
Dashboards/Maps
1
Countries / Regions
India
493
Global
374
South Africa
264
Kenya
246
Sierra Leone
237
Liberia
227
Western and Central Europe
212
Congo, Democratic Republic of
203
Nigeria
179
Ethiopia
175
Africa
174
Uganda
171
Germany
157
Senegal
155
Latin America and the Carribbean
143
Rwanda
132
Malawi
127
Tanzania
126
Nepal
123
Guinea
122
Burkina Faso
116
Russia
114
Syria
110
Zambia
107
Ukraine
106
Bangladesh
100
Myanmar / Burma
100
Ghana
99
West and Central Africa
96
Eastern Europe
89
Haiti
85
Brazil
81
Namibia
72
Philippines
69
East and Southern Africa
68
Mozambique
67
Middle East and North Africa
67
Indonesia
66
Mali
63
Benin
63
Cameroon
61
South Sudan
56
Cambodia
54
South–East Asia Region
54
Lesotho
51
Asia
51
Côte d’Ivoire / Ivory Coast
50
Zimbabwe
50
Venezuela
47
Madagascar
44
Yemen
40
Eastern Europe and Central Asia
40
Colombia
34
Botswana
34
Central African Republic
31
Peru
28
Eswatini/ Swaziland
27
Angola
27
USA
26
Chad
26
Argentina
26
Niger
25
Ecuador
21
Paraguay
21
Chile
20
Western Pacific Region
19
Guinea-Bissau
17
Togo
16
Pakistan
16
Tajikistan
15
Spain
15
Somalia
14
Iraq
14
Sudan
14
Bolivia
14
Vietnam
14
Afghanistan
13
Thailand
12
Albania
12
Lebanon
11
China
11
Georgia
11
Jordan
10
El Salvador
10
Sri Lanka
10
Laos
10
United Kingdom
10
Palestine
9
Southern Africa
9
Moldova
9
North America
9
Burundi
8
Mexico
8
France
8
Switzerland
7
Armenia
7
Saudi Arabia
6
Turkey
6
North Macedonia
6
Morocco
5
Egypt
5
Ireland
5
Papua New Guinea
5
Bhutan
5
Canada
5
Kazakhstan
5
Jamaica
5
Gambia
4
Hungary
4
Honduras
4
Greece
4
Libya
4
Poland
4
Congo-Brazzaville
4
Romania
4
Iran
4
Uzbekistan
4
Kyrgyzstan
4
Singapore
3
Austria
3
Serbia
3
Guatemala
3
Italy
3
Timor Leste/ East Timor
3
Estonia
3
Mauritius
3
Portugal
3
Malaysia
2
Nicaragua
2
Other region
2
Fiji
2
Bulgaria
2
Lithuania
2
Slovakia
2
Australia
2
Gabon
2
Uruguay
2
Belgium
2
Tunisia
2
Belarus
2
Mauritania
1
Luxembourg
1
Solomon Islands
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Norway
1
South Korea
1
Algeria
1
French Guyana
1
Israel
1
Latvia
1
United Arab Emirates
1
Authors & Publishers
Publication Years
Category
Countries
3933
Clinical Guidelines
969
Public Health
559
Women & Child Health
393
Key Resources
338
Capacity Building
239
Pharmacy & Technologies
128
Annual Report MEDBOX
2
Toolboxes
COVID-19
1408
Mental Health
856
TB
727
HIV
718
Ebola
592
Caregiver
434
AMR
374
Rapid Response
361
NTDs
315
NCDs
287
Refugee
275
Pharmacy
223
Conflict
214
Disability
198
Planetary Health
163
Global Health Education
108
Cholera
101
Zika
84
Natural Hazards
77
Specific Hazards
63
Polio
54
Health Financing Toolbox
44
Social Ethics
42
Typhoon
3
South Sudan
1
Health Financing
1
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection of Buruli ulcer in symptomatic ... with sufficient positive predictive value to put patients on appropriate treatment; and
a screening test at the primary health care or community level for symptomatic patients with ulcer
In March 2018, they convened a global meeting with the aim of establishing an action plan to develop new diagnostic solutions for Buruli ulcer and to create a framework of collaboration to address unmet needs in diagnostics for the disease. The participants agreed to develop a target product profile (TPP) to address the need for a rapid diagnostic test for use at the primary health-care level.
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative ...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is...
Un(e) infirmier/ière travaille dans le secteur des soins de santé et est en charge de certains types d'actes
médicaux et de soins aux patients. Il/elle exerce ses fonctions en concertation avec un médecin ou les exécute de sa propre initiative...
During the COVID-19 pandemic, healthcare providers in areas where dengue is endemic or who are treating patients with recent travel history to these areas, need to consider dengue and COVID-19 in the differential diagnosis of acute febrile illnesses...
The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal <... care pathway, and explores the roadblocks along the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.
To conduct a study in a small rural hospital located in the state of Chiapas, Mexico, to: examine the prevalence of chagasic cardiomyopathy among patients with the diagnosis of congestive heart failure and assess the prevalence of positive serologic...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients unde...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of ... with
the leprosy infection. Furthermore, the relapse rate is very low, at about 1% over 5–10 years.
There is little M. leprae drug resistance in leprosy and few reports of multi-drug resistance (1, 2, 3,
4, 5, 6, 7, 8). An antibiotic treatment may take months or years to produce clinical improvement,
especially in patients with an initial high bacterial index (BI).
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in An...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT ... where the genetic mechanism has been established.
The current goal of elimination of HAT as a public health problem by 2020 may be undermined by the emergence and spread of resistance to current or new drugs.
Insights into potential resistance mechanisms for current and new drugs will facilitate predictions of the likelihood of resistance and will also facilitate rational approaches to minimizing, monitoring, and tackling the future emergence of resistance.
Treatment of second-stage gambiense human African trypanosomiasis relied on toxicarsenic-based derivatives for over 50 years. The availability and subsequent use of eflornithine,initially in monotherapy and more recently in combination with nifurtimox (NECT), has drasticallyimproved the pro...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in ... 6 years of age and older and weighing at least 20 kg.
Limitations of Use
Due to the decreased efficacy observed in patients with severe second stage HAT (cerebrospinal fluid white blood cell count (CSF-WBC) >100 cells/μL) due to T. brucei gambiense disease, Fexinidazole Tablets should only be used in these patients if there are no other available treatment options [see Warnings and Precautions (5.1)]
Sleeping sickness is a neglected tropical disease affecting rural communities in sub-Saharan Africa. The reduction in the number of reported cases in recent years indicates that disease transmission is under control. However, many aspects of patient...
About a year after infection, a painful blister forms – 90% of the time on the lower leg – and one or more worms emerge accompanied by a burning sensation. To soothe the burning pain, patients often immerse the infected part of the body in water...
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, ... with CBM require long term therapy with systemic antifungals, sometimes associated with physical methods. Unlike other neglected endemic mycoses, comparative clinical trials have not been performed for this disease. Nowadays, therapy is based on a few open trials and on expert opinion. Itraconazole either as monotherapy or associated with other drugs, or with physical methods, is widely used. Recently, photodynamic therapy has been successfully employed in combination with antifungals in patients presenting with CBM. In the present revision the most used therapeutic options against CBM are reviewed as well as the several factors that may have impact on the patient's outcome.
Scabies is a contagious skin condition caused by the mite Sarcoptes scabiei which burrows into the skin and causes severe itching. Scabies is transmitted by direct skin-to-skin contact or indirectly by contact with contaminated material (fomites). This condition is often challenging to diagnose as m...
The purpose of this document is to contribute to improved recognition of Buruli
ulcer (Mycobacterium ulcerans infection) and encourage greater efforts in detecting
cases at an early stage of infection.Today, patients can be cured with antibiotics ...
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin.
The only treatment available for cutaneous leishmaniasis is highly toxic. In some cases, patients have died because...
Diabetes mellitus (DM) is a global epidemic with significant morbidity. Diabetic
retinopathy (DR) is the specific microvascular complication of DM and affects 1 in 3 persons with DM. DR remains a leading cause of vision loss in working adult populations. ... with severe levels of DR are reported to have poorer quality of life and reduced levels of physical, emotional, and social well-being, and they utilize more health care resources.
Epidemiological studies and clinical trials have shown that optimal control of blood glucose, blood pressure, and blood lipids can reduce the risk of developing retinopathy and slow its progression. Timely treatment with laser photocoagulation, and increasingly, the appropriate use of intraocular administration of vascular endothelial growth factor (VEGF) inhibitors can prevent visual loss in vision- threatening retinopathy, particularly diabetic macular edema (DME). Since visual loss may not be present in the earlier stages of retinopathy, regular screening of persons with diabetes is essential to enable early intervention.
